Author: Ravi Shankar

SAN DIEGO, Oct. 21, 2026 (GLOBE NEWSWIRE) — Beam Global (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for energy storage and security, future of mobility, and smart city infrastructure, today announced that the Dry Creek Rancheria Band of Pomo Indians has deployed five EV ARC™ off-grid, solar-powered electric vehicle (EV) charging systems in California and ordered an ARC Mobility™ Trailer to complement the deployment. Together with the three EV ARC™ systems sold to the Twenty-Nine Palms Band of Mission Indians in Coachella, eight Beam Global EV ARC™ systems are now deployed across these two California-based tribal communities.

Beam Global has previously sold solutions to other tribal communities, including Northwest Indian College serving the Lummi Nation in Washington and the Confederated Tribes of Grand Ronde in Oregon. With 575 federally recognized tribes in the United States, Beam views its growing list of deployments as a significant opportunity to expand its presence in this market particularly because eligible tribal governments can also qualify for direct payments equal to 30% of qualifying investments in eligible clean electricity generation and energy storage under the federal Clean Electricity Investment Credit (Section 48E).

The EV ARC™ systems deployed for the Dry Creek Rancheria Band of Pomo Indians were supported by a California Energy Commission grant to expand EV charging access on tribally owned land. The systems were purchased through Beam Global’s U.S. General Services Administration (GSA) contract.

“Rising prices for gasoline and diesel at the pump, along with increasing costs and pressures on electrical infrastructure caused by AI data centers and the electrification of almost everything, provide yet more reasons why Beam Global’s rapidly deployed off-grid EV charging and emergency power energy infrastructure solutions make so much sense,” said Desmond Wheatley, CEO of Beam Global. “We are delighted to support tribal communities who have such a long and honorable history of husbanding natural resources. We look forward to continuing to grow this segment of our business by enabling Indigenous communities across the country to save money and become increasingly energy independent.”

EV ARC™ systems generate and store their own renewable electricity, using integrated solar panels and store that energy in Beam Global’s proprietary onboard battery storage. This provides EV charging without the need for construction, trenching, a utility grid connection, or electrical permitting. Their self-contained design enables deployment in locations where traditional charging infrastructure may be costly, time-consuming, or difficult to install.

These capabilities can help tribal communities advance energy sovereignty, improve resilience and bring charging infrastructure to remote locations where traditional grid connections may be too expensive, too disruptive, or impossible to establish. The additional ARC Mobility™ Trailer ordered by the Dry Creek Rancheria Band of Pomo Indians will complement the five deployed systems, allowing charging infrastructure to be transported and relocated as needs change.

For more information about Beam Global’s sustainable EV charging solutions, visit www.BeamForAll.com or contact BeamTeam@BeamForAll.com.

About Beam Global

Beam Global is a sustainable technology innovator that develops and manufactures infrastructure products and technologies. The Company operates at the nexus of innovative and reliable energy, transportation and smart city solutions with a focus on sustainable energy infrastructure, rapidly deployed and scalable EV charging solutions, safe energy storage, energy security and intelligent infrastructure. With operations in the U.S., Europe and the Middle East, Beam Global develops, patents, designs, engineers and manufactures unique and advanced technology solutions that power transportation, provide secure sources of electricity, enable smart city services, save time and money, and protect the environment. Beam Global is headquartered in San Diego, CA, with facilities in Yuma, AZ; Broadview, IL; Belgrade and Kraljevo, Serbia; and Abu Dhabi, UAE. Beam Global is listed on Nasdaq under the symbol BEEM. For more information visit BeamForAll.com, LinkedIn, YouTube, Instagram and X.

Forward-Looking Statements

This Beam Global Press Release may contain forward-looking statements. All statements in this Press Release other than statements of historical facts are forward-looking statements. Forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “anticipate,” “target,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may,” or other words and similar expressions that convey the uncertainty of future events or results. These statements relate to future events or future results of operations. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause Beam Global’s actual results to be materially different from these forward-looking statements. Except to the extent required by law, Beam Global expressly disclaims any obligation to update any forward-looking statements.

Investor Relations
Luke Higgins
+1 858-261-7646
IR@BeamForAll.com

Media Contact
Lisa Potok
+1 858-327-9123
Press@BeamForAll.com

PRINCETON, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2026.

Third Quarter 2026 Highlights

• Third quarter revenues of $411.2 million increased 2.3% on a reported basis and 2.5% on an organic basis compared to the prior year. Results included an approximate $7 million revenue impact related to flood damage at the Company’s Cincinnati facility.
• Third quarter GAAP earnings per diluted share of $0.19, compared to $(0.07) in the prior year.
• Adjusted earnings per diluted share of $0.59, compared to $0.54 in the prior year.
• Generated operating cash flow of $96.0 million and reduced the consolidated total leverage ratio to 3.8x.
• Subsequent to quarter-end, completed a $2.1 billion debt refinancing that extended debt maturities and enhanced financial flexibility.
• 2026 full-year revenue guidance of $1.634 billion to $1.654 billion and adjusted earnings per share guidance of $2.30 to $2.40, consistent with the outlook provided on October 2, 2026.

“Our third quarter performance reflected mixed results across our portfolio, with stronger performance in Specialty Surgery partially offset by a $7 million impact from the Cincinnati disruption and softer-than-expected results in Tissue Reconstruction. We delivered results within our guidance ranges, generated strong cash flow, reduced leverage, and subsequently completed our debt refinancing,” said Stuart Essig, Chairman and Chief Executive Officer.

“Our updated outlook reflects both the recovery timeline in Cincinnati and more measured expectations for portions of our Tissue Reconstruction business. We are focused on executing against these challenges while continuing to support our customers, advance key product launches and returns, and strengthen the business for more consistent long-term growth.”                             

Third Quarter 2026 Consolidated Performance

Total reported revenues of $411.2 million increased 2.3% on a reported basis and 2.5% on an organic basis compared to the prior year.

The Company reported GAAP gross margin of 51.0%, compared to 51.5% in the third quarter of 2025. Adjusted gross margin was 61.1%, compared to 62.9% in the prior year.

Adjusted EBITDA for the third quarter of 2026 was $79.8 million, or 19.4% of revenue, compared to $78.5 million, or 19.5% of revenue, in the prior year.

The Company reported GAAP net income of $14.9 million, or $0.19 per diluted share, in the third quarter of 2026, compared to GAAP net loss of $(5.4) million, or $(0.07) per diluted share, in the prior year.

Adjusted net income for the third quarter of 2026 was $46.4 million, or $0.59 per diluted share, compared to $41.6 million, or $0.54 per diluted share, in the prior year.

Third Quarter 2026 Segment Performance

Specialty Surgery (~70% of Revenues)

Total revenues were $304.1 million, representing reported growth of 3.9% and an organic growth of 4.2% compared to the third quarter of 2025. Results were impacted by approximately $7 million related to flood damage at the Company’s Cincinnati facility.

• Sales in Neuro increased 6.5% on an organic basis primarily driven by growth in CereLink®, Certas® Plus, Bactiseal®, DuraSeal® and recovery in cranial perforators.
• Sales in Instruments declined (0.9%) on an organic basis due to order timing.
• ENT sales declined (1.1%), largely due to a low-single digit decline in sinus balloons.

Tissue Reconstruction (~30% of Revenues)

Total revenues were $107.1 million, representing reported and organic decline of (2.2)% compared to the third quarter of 2025. Key drivers for the quarter include:

• Low-single digit decline in wound reconstruction, with strong growth in DuraSorb® and PriMatrix®, offset by declines in MicroMatrix® and Integra Skin.
• Beginning this quarter, we are referring to our Private Label business as Corporate Partnerships, a name that better reflects the nature of these customer relationships. Corporate Partnerships, was approximately flat compared to the third quarter of last year.

Balance Sheet, Cash Flow and Capital Allocation

The Company generated cash flow from operations of $96.0 million in the quarter. Net debt at the end of the quarter was $1.5 billion, and the consolidated total leverage ratio was 3.8x.

As of the end of the quarter, the Company had total liquidity of approximately $559 million, including $311.9 million in cash plus short-term investments and the remainder available under its revolving credit facility.

Debt Refinancing and Enhanced Financial Flexibility

On October 19, 2026, the Company completed a $2.1 billion debt refinancing consisting of a $1.65 billion senior secured credit facility and $450 million aggregate principal amount of 9.5% senior secured notes due 2033. The new credit facility consists of a $600 million Term Loan A, a $600 million revolving credit facility, and a $450 million Term Loan B.

The Company used the proceeds from the refinancing to repay its existing credit facilities and pay related fees and expenses. The transaction extended the Company’s debt maturity profile, enhanced financial flexibility, and supports the Company’s continued focus on cash generation and deleveraging. Additional information regarding the refinancing is available in the Company’s filings with the Securities and Exchange Commission.

Related to the refinancing, the amended debt covenants provide additional near-term covenant capacity by temporarily increasing the Company’s maximum allowable net leverage ratio from its current level followed by scheduled step-downs to 4.25x during 2027. Under the previous covenants the step down for 2027 was to 4.0x. The Company expects the increase in its effective interest rate to be near the high end of the previously communicated 100- to 200-basis-point range.

2026 Revenue and Adjusted Earnings Per Share Guidance

For the fourth quarter of 2026, the Company expects reported revenues in the range of $413 million to $433 million, representing a reported decline of -5.2% to -0.5% and an organic decline of -5.1% to -0.4%. The Company expects adjusted earnings per diluted share in the range of $0.61 to $0.71.

For the full year 2026, the Company expects revenues in the range of $1.634 billion to $1.654 billion representing reported growth of -0.1% to 1.2% and organic growth of -0.3% to 0.9%. The Company expects adjusted earnings per diluted share in the range of $2.30 to $2.40. The Company continues to expect operating cash flow of approximately $190 million to $200 million for the full year. These expectations are consistent with the preliminary results and updated guidance provided on October 2, 2026.

The updated fourth quarter and full-year outlook reflects the expected revenue impact of the Cincinnati disruption, an updated outlook for Tissue Reconstruction performance, and a consistent outlook for Specialty Surgery. The adjusted earnings per diluted share outlook also reflects business interruption insurance recoveries for lost revenue related to the Cincinnati disruption and incremental interest expense associated with the refinancing.

Conference Call and Presentation Available Online

Integra has scheduled a conference call for 8:30 a.m. ET on Wednesday, October 21, 2026, to discuss third quarter 2026 financial results and forward looking financial guidance. The conference call will be hosted by Integra’s senior management team and will be open to all listeners. Additional forward looking information may be discussed in a question and answer session following the call. Integra’s management team will reference a presentation during the conference call, which can be found in the Investor Relations section of the Company’s website at investor.integralife.com. A live webcast will also be available in the Investor Relations section of the Company’s website at investor.integralife.com.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, it is recommended to join 10 minutes prior to the event’s start. A webcast replay of the conference call will be available on the Investors section of the company’s website following the call.

About Integra

Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties and reflect the Company’s judgment as of the date of this release. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. Some of these forward-looking statements may contain words like “will,” “believe,” “may,” “could,” “would,” “might,” “possible,” “should,” “expect,” “intend,” “forecast,” “guidance,” “plan,” “anticipate,” “target,” or “continue,” the negative of these words, other terms of similar meaning or they may use future dates. Forward-looking statements contained in this news release include, but are not limited to, statements concerning: future business, operational and financial performance and the Company’s expectations and plans with respect to market opportunity, business and operational performance, strategic initiatives, capabilities, resources, manufacturing capabilities, product development, product availability and regulatory approvals, including expectations regarding the Company’s Braintree facility and the relaunch of SurgiMend in the fourth quarter of 2026, and the estimated impact of the flooding event at our Cincinnati, Ohio manufacturing facility (the “Cincinnati facility”), including on our financial condition and results of operations, and our expectations and progress in our recovery efforts, including timing, costs and expected insurance coverage and reimbursements. It is important to note that the Company’s goals and expectations are not predictions of actual performance. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Such risks and uncertainties include, but are not limited, to the following: increased geopolitical instability and other macroeconomic factors, including trade barriers and related restrictions (including tariffs and related countermeasures), armed conflict and acts of terrorism, geopolitical tension and instability, supply chain disruptions, and interest rate and foreign currency rate fluctuations, on the Company’s suppliers, vendors and customers and on the Company’s business and financial condition, results of operations and cash flows; the Company’s ability to execute its financial, strategic and operating plans effectively; the Company’s ability to remediate quality systems violations; difficulties in implementing the Company’s compliance master plan; difficulties or delays in obtaining and maintaining required regulatory approvals, including the costs thereof; potential difficulties, delays and disruptions in manufacturing, distribution or sale of products; difficulties or delays, including unexpected costs and the availability of insurance coverage and reimbursements, related to the Company’s Cincinnati facility recovery efforts; the failure of the company’s suppliers, vendors, and other third parties to meet contractual, regulatory and other obligations; the anticipated development of markets the Company sells its products into and the success of the Company’s products in these markets; the Company’s ability to predict accurately the demand for its products and products under development; increasing industry competition; the coverage and reimbursement decisions of third-party payors; trends toward health care cost containment; difficulties in controlling expenses, including costs to procure and manufacture the Company’s products; the ability of the Company to successfully manage leadership and organizational changes and the impact of changes in management or staff levels; the impact of goodwill and intangible asset impairment charges if future operating results of acquired businesses are significantly less than the results anticipated at the time of the acquisitions, the geographic distribution of where the Company generates its taxable income; changes to applicable laws, regulations and enforcement guidance, including tax laws and global health care reforms; fluctuations in foreign currency exchange rates; the amount of our bank borrowings outstanding and other factors influencing liquidity; breaches, failures or other disruptions of our or our vendors’ or customers’ information technology systems or products; and the economic, competitive, governmental, technological, and other risk factors and uncertainties identified under the heading “Risk Factors” included in Item 1A of Integra’s Annual Report on Form 10-K for the year ended December 31, 2025 and information contained in subsequent filings with the Securities and Exchange Commission.

These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events, or otherwise, except as otherwise required by law.

Discussion of Adjusted Financial Measures
In addition to our GAAP results, we provide certain non-GAAP measures, including organic revenues, adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted net income, adjusted gross margin, adjusted earnings per diluted share, and net debt. Organic revenues consist of total revenues excluding the effects of currency exchange rates, revenues from current-period acquisitions and product divestitures. Adjusted EBITDA consists of GAAP net income excluding: (i) depreciation and amortization; (ii) other income (expense); (iii) interest income and expense; (iv) income tax expense (benefit); (v) impairment charges; and (vi) those operating expenses also excluded from adjusted net income.   The measure of adjusted net income consists of GAAP net income, excluding: (i) structural optimization charges; (ii) divestiture, acquisition and integration-related charges; (iii) EU Medical Device Regulation-related charges; (iv) charges related to the transition of Boston-related manufacturing operations to the Company’s Braintree, Massachusetts facility (the “Braintree transition”); (v) charges related to the flooding of the Company’s Cincinnati, Ohio manufacturing facility, including inventory losses, asset write-offs, remediation costs, plant restart costs and other directly related costs, net of associated insurance reimbursements, as applicable (the “Cincinnati flood and recovery”); (vi) intangible asset amortization expense; (vii) income tax impact from adjustments; and (vii) impairment charges. The measure of adjusted gross margin is calculated by dividing adjusted gross profit by total revenues. Adjusted gross profit consists of GAAP gross profit adjusted for: (i) structural optimization charges; (ii) divestiture, acquisition and integration-related charges; (iii) charges related to Braintree transition; (iv) EU Medical Device Regulation-related charges; (v) charges related to the Cincinnati flood and recovery; and (vi) intangible asset amortization expense. The adjusted earnings per diluted share measure is calculated by dividing adjusted net income attributable to diluted shares by diluted weighted average shares outstanding. The measure of net debt consists of GAAP total debt (excluding deferred financing costs) less short-term investments, cash and cash equivalents.

The Company has included reconciliations of GAAP revenues to organic revenues, GAAP net income to adjusted EBITDA, and adjusted net income, GAAP gross margin to adjusted gross margin, and GAAP earnings per diluted share to adjusted earnings per diluted share all for the quarters ended June 30, 2026 and 2025. The Company has included a reconciliation of GAAP total debt to net debt for the quarters ended June 30, 2026 and December 31, 2025.  

The Company is providing forward-looking guidance regarding organic revenue and adjusted earnings per diluted share but is not providing reconciliations to the most directly comparable forward-looking GAAP financial measures because certain GAAP expense items and the impact of changes in foreign exchange rates are highly variable and management is unable to predict them with reasonable certainty and without unreasonable effort. Specifically, the actual impact of changes in foreign exchange rates and the financial impact and timing of divestitures, acquisitions, integrations, structural optimization, efforts to comply with the EU Medical Device Regulation, and income tax impact from adjustments are uncertain, depend on various dynamic factors and are not reasonably ascertainable at this time. The unavailable information could have a material impact on GAAP results.

The Company believes that the presentation of organic revenues and the other non-GAAP measures provide important supplemental information to management and investors regarding financial and business trends relating to the Company’s financial condition and results of operations.   For further information regarding why Integra believes that these non-GAAP financial measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the Company’s Current Report on Form 8-K regarding this earnings press release filed today with the Securities and Exchange Commission. This Current Report on Form 8-K is available on the SEC’s website at   www.sec.gov or on our website at www.integralife.com.  

Investor Relations Contact:
Chris Ward
(609) 772-7736
chris.ward@integralife.com

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com

INTEGRA LIFESCIENCES HOLDINGS CORPORATION  CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS  (UNAUDITED)
(In thousands, except per share amounts)
		Three Months Ended September 30,
			2026				2025
Total revenue, net		$	411,182			$	402,062
Costs and expenses:
Cost of goods sold			201,316				195,071
Research and development			21,897				22,456
Selling, general and administrative			165,311				169,046
Intangible asset amortization			3,758				3,728
Goodwill impairment charge			—				—
Total costs and expenses			392,282				390,301
Operating income (loss)			18,900				11,761
Interest income			5,002				4,982
Interest expense			(22,961	)			(22,725	)
Other income (expense), net			14,723				(842	)
Income (loss) before income taxes			15,664				(6,824	)
Provision (benefit) for income taxes			812				(1,420	)
Net income (loss)		$	14,852			$	(5,404	)
Net income (loss) per share
Diluted		$	0.19			$	(0.07	)
Weighted average common shares outstanding			78,577				76,753

The following table presents revenues disaggregated by the major sources for the three months ended September 30, 2026 and 2025 (amounts in thousands):
		Three Months Ended September 30,
			2026		2025	Change
Neurosurgery		$	214,097	$	201,563	6.2%
Instruments			49,662		50,151	(1.0)%
ENT			40,361		40,869	(1.2)%
Total Specialty Surgical			304,120		292,583	3.9%
Wound Reconstruction Solutions			81,529		83,988	(2.9)%
Corporate Partnerships			25,533		25,491	0.2%
Total Tissue Reconstruction			107,062		109,479	(2.2)%
Total Reported Revenues		$	411,182	$	402,062	2.3%
Impact of changes in currency exchange rates			810		—
Total organic revenues(1)		$	411,992	$	402,062	2.5%

(1) Organic revenues have been adjusted to exclude foreign currency (current period), acquisitions and to account for divested and discontinued products.

Items included in GAAP net income and location where each item is recorded are as follows:

(In thousands)

Three Months Ended September 30, 2026
Item	Total Amount		COGS(a)	SG&A(b)	R&D(c)		Amort (d)	OI&E(e)		Tax(f)
Acquisition, divestiture and integration-related charges	(3,026	)	82	2,211	(1,322	)	—	(3,997	)	—
Structural Optimization charges	5,742		3,486	1,322	935		—	—		—
EU Medical Device Regulation charges	2,556		297	760	1,499		—	—		—
Braintree Transition	8,772		8,770	1	—		—	—		—
Cincinnati Flood	782		5,709	—	—		—	(4,927	)	—
Intangible asset amortization expense	26,850		23,091	—	—		3,758	—		—
Estimated income tax impact from above adjustments and other items	(10,083	)	—	—	—		—	—		(10,083	)
Depreciation expense	10,287		—	—	—		—	—		—

a) COGS – Cost of goods sold
b) SG&A – Selling, general and administrative
c) R&D – Research & development
d) Amort. – Intangible asset amortization
e) OI&E – Other income & expense
f) Tax – Income tax expense (benefit)

Items included in GAAP net income and location where each item is recorded are as follows:

(In thousands)

Three Months Ended September 30, 2025
Item	Total Amount		COGS(a)	SG&A(b)		R&D(c)		Amort (d)	OI&E(e)	Tax(f)
Acquisition, divestiture and integration-related charges	(6,588	)	177	(6,182	)	(1,029	)	—	445	—
Structural Optimization charges	11,052		8,413	2,786		(146	)	—	—	—
EU Medical Device Regulation charges	10,554		808	5,396		4,350		—	—	—
Braintree Transition	13,957		13,447	510		—		—	—	—
Intangible asset amortization expense	26,873		23,145	—		—		3,728	—
Estimated income tax impact from above adjustments and other items	(8,823	)	—	—		—		—	—	(8,823	)
Depreciation expense	11,289		—	—		—		—	—	—

a)  COGS – Cost of goods sol
b)  SG&A – Selling, general and administrative
c)  R&D – Research & development
d)  Amort. – Intangible asset amortization
e)  OI&E – Other income & expense
f)  Tax – Income tax expense (benefit)

RECONCILIATION OF NON-GAAP ADJUSTMENTS – GAAP NET INCOME TO ADJUSTED EBITDA (UNAUDITED)
(In thousands)
		Three Months Ended September 30,
			2026				2025
GAAP net income (loss)		$	14,852			$	(5,404	)
Non-GAAP adjustments:
Depreciation and intangible asset amortization expense			37,137				38,162
Other (income) expense, net			(5,545	)			842
Interest expense, net			17,706				17,298
Income tax expense			812				(1,420	)
Structural optimization charges			5,742				11,052
EU Medical Device Regulation charges			2,556				10,554
Braintree Transition			8,772				13,957
Cincinnati Flood			782				—
Acquisition, divestiture and integration-related charges			(3,026	)			(6,588	)
Total of non-GAAP adjustments			64,936				83,857
Adjusted EBITDA		$	79,787			$	78,453

RECONCILIATION OF NON-GAAP ADJUSTMENTS – GAAP NET INCOME TO MEASURES OF ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE (UNAUDITED)
(In thousands, except per share amounts)
		Three Months Ended September 30,
			2026				2025
GAAP net income (loss)		$	14,852			$	(5,404	)
Non-GAAP adjustments:
Structural optimization charges			5,742				11,052
Acquisition, divestiture and integration-related charges			(3,026	)			(6,588	)
EU Medical Device Regulation charges			2,556				10,554
Braintree Transition			8,772				13,957
Cincinnati Flood			782				—
Intangible asset amortization expense			26,850				26,873
Estimated income tax impact from adjustments and other items			(10,083	)			(8,823	)
Total of non-GAAP adjustments			31,592				47,025
Adjusted net income		$	46,444			$	41,621
Adjusted diluted net income per share		$	0.59				0.54
Weighted average common shares outstanding for diluted net income per share			78,577				76,850

CONDENSED BALANCE SHEET DATA (UNAUDITED)
(In thousands)
		September 30, 2026			December 31, 2025
Short term investments		$	59,669		$	28,693
Cash and cash equivalents			252,261			235,048
Trade accounts receivable, net			248,994			278,849
Inventories, net			464,454			492,735
Current and long-term borrowing under senior credit facility			1,745,388			1,768,306
Borrowings under securitization facility			81,200			87,800
Convertible securities			—			—
Stockholders’ equity		$	1,066,617		$	1,043,463

CONDENSED STATEMENT OF CASH FLOWS (UNAUDITED)
(In thousands)
		Nine Months Ended September 30,
			2026				2025
Net cash provided by operating activities		$	128,582			$	38,568
Net cash (used in) investing activities			(68,377	)			(73,156	)
Net cash (used in) provided by financing activities			(38,809	)			3,993
Effect of exchange rate changes on cash and cash equivalents			(4,183	)			16,406
Net increase (decrease) in cash and cash equivalents		$	17,213			$	(14,189	)

RECONCILIATION OF NON-GAAP ADJUSTMENTS – GAAP OPERATING CASH FLOW TO MEASURES OF FREE CASH FLOW AND ADJUSTED FREE CASH FLOW CONVERSION (UNAUDITED)
(In thousands)
		Three Months Ended September 30,
			2026			2025
Net cash provided by operating activities		$	95,977		$	40,907
Purchases of property and equipment			(10,246	)		(15,156	)
Free cash flow		$	85,731		$	25,751
Adjusted net income(1)		$	46,444		$	41,621
Adjusted free cash flow conversion			184.6	%		61.9	%
		Twelve Months Ended September 30,
			2026			2025
Net cash provided by operating activities		$	140,397		$	89,315
Purchases of property and equipment			(54,615	)		(93,821	)
Free cash flow		$	85,782		$	(4,506	)
Adjusted net income(1)		$	195,456		$	180,896
Adjusted free cash flow conversion			43.9	%	(2.5)        %

(1) Adjusted net income for quarters ended September 30, 2026 and 2025 are reconciled above. Adjusted net income for remaining quarters in the trailing twelve months calculation have been previously reconciled and are publicly available in the Quarterly Earnings Call Presentations on our website at investor.integralife.com under Events & Presentations.

The Company calculates adjusted free cash flow conversion by dividing its free cash flow by adjusted net income. The Company believes this measure is useful in evaluating the significance of the cash special charges in its adjusted earnings measures.

RECONCILIATION OF NON-GAAP ADJUSTMENTS – NET DEBT CALCULATION (UNAUDITED)
(In thousands)
		September 30, 2026			December 31, 2025
Short-term borrowings under senior credit facility		$	48,438		$	38,750
Long-term borrowings under senior credit facility			1,696,950			1,729,556
Borrowings under securitization facility			81,200			87,800
Convertible securities			—			—
Deferred financing costs netted in the above			2,112			3,257
Short term investments			(59,669	)		(28,693	)
Cash & Cash Equivalents			(252,261	)		(235,048	)
Net Debt		$	1,516,770		$	1,595,622

RECONCILIATION OF NON-GAAP ADJUSTMENTS – GAAP GROSS PROFIT TO MEASURES OF ADJUSTED GROSS PROFIT AND ADJUSTED GROSS MARGIN (UNAUDITED)
(In thousands, except percentages)
		Three Months Ended September 30,
			2026				2025
Total revenues, net		$	411,182			$	402,062
Cost of goods sold			201,316				195,071
Reported Gross Profit			209,866				206,991
Cincinnati Flood			5,709				—
Structural optimization charges			3,486				8,413
Acquisition, divestiture and integration-related charges			82				177
Braintree Transition			8,770				13,447
EU Medical Device Regulation			297				808
Intangible asset amortization expense			23,091				23,145
Adjusted Gross Profit		$	251,302			$	252,981
Total Revenues		$	411,182			$	402,062
Adjusted Gross Margin			61.1	%			62.9	%

Deutsche Lufthansa AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution

21. Oct 2026 / 11:54 CET/CEST, transmitted by GlobeNewswire.

The issuer is solely responsible for the content of this announcement.

---

Notification of Major Holdings

1. Details of issuer

2. Reason for notification

3. Details of person subject to the notification obligation

Legal entity

4. Name(s) of shareholder(s) holding directly 3% or more voting rights, if different from details of person subject to the notification obligation

5. Date on which threshold was crossed or reached

6. Total positions

7. Details on total positions

a. Voting rights attached to shares (Sec. 33, 34 WpHG)

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

8. Information in relation to the person subject to the notification obligation

9. In case of proxy voting according to Sec. 34 (3) WpHG

Date of general meeting

Total positions (6.) after general meeting:

10. Other useful information

Date

End of message

---

GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.

Archive at www.globenewswire.com

---

Platform Brings Together NVIDIA Vera Rubin, Vera CPUs and BlueField-4 to Power Enterprise Infrastructure to Build, Run, Observe and Enforce Safe Agents at Industrial Scale

News Summary:

• The NVIDIA OpenShell Reference Architecture delivers enterprise governance, isolation and security for building, containing, observing and enforcing safe agents across enterprise infrastructure and edge systems.
• Built on the foundation of NVIDIA OpenShell secure runtime software, the architecture brings together NVIDIA Vera Rubin infrastructure for model inference, NVIDIA Vera CPUs for agent harnesses and tool use, and NVIDIA BlueField-4 DPUs running NVIDIA Sentry for in-silicon enforcement. The OpenShell Reference Architecture extends to the edge with NVIDIA RTX Spark, NVIDIA DGX Spark and NVIDIA DGX Station systems.
• The OpenShell Reference Architecture runs on leading enterprise operating systems, including Canonical, Red Hat, and Microsoft Windows and Microsoft Execution Containers.
• Anthropic, AWS, Cisco, CrowdStrike, Dassault Systèmes, Dell Technologies, Google Cloud, HPE, IBM, Meta, Microsoft, OpenAI, Palo Alto Networks, Perplexity, SAP, ServiceNow, Siemens, SpaceX Super Intelligence and others are among those working with the OpenShell Reference Architecture to enhance the security of agent deployments.

BERLIN, Oct. 21, 2026 (GLOBE NEWSWIRE) — GTC Berlin — NVIDIA today announced the NVIDIA OpenShell Reference Architecture, which enables building, containing, observing and enforcing safe agents on enterprise infrastructure and edge systems.

The OpenShell Reference Architecture builds on the foundation of NVIDIA OpenShell™ secure runtime software, extending it into full-stack, industrial-scale infrastructure for agent development and operations.

It includes NVIDIA Vera Rubin infrastructure for running enterprise workloads, including closed and open models built with NVIDIA Nemotron™; NVIDIA Vera CPUs for operating agent harnesses; open source NVIDIA OpenShell software; and NVIDIA BlueField^® DPUs for running the NVIDIA Sentry unified security software framework that provides continuous out-of-band monitoring of agent behavior and in-silicon policy enforcement.

The OpenShell Reference Architecture is extensible to agents running at the edge across industries such as retail, healthcare, manufacturing, robotics, software development and telecommunications with NVIDIA RTX Spark™, NVIDIA DGX Spark™ and NVIDIA DGX Station™ systems.

“AI capability and safety must advance together,” said Jensen Huang, founder and CEO of NVIDIA. “As enterprises prepare to deploy billions of AI agents, safety and control must be built into the computing architecture. NVIDIA created OpenShell to give agents the freedom to do useful work within clearly defined boundaries — contained, monitored and under control. With the OpenShell Reference Architecture, agents can think on Rubin, act on Vera and be governed on BlueField.”

Full-Stack Infrastructure Built for Agents
The OpenShell Reference Architecture features NVIDIA accelerated computing paired with software for secure agent operations.

• NVIDIA Vera Rubin, with NVIDIA Vera Rubin NVL72 infrastructure at its core, is fungible across pretraining, post-training and inference. For agentic workloads, NVIDIA Vera Rubin NVL72 systems deliver 30x higher throughput per megawatt.
• NVIDIA Vera CPUs deliver 2x the performance of x86 processors with greater energy efficiency and run NVIDIA OpenShell, which provides a secure runtime boundary for autonomous agents.
• NVIDIA BlueField-4 DPUs continuously monitor agent behavior with NVIDIA Sentry, built on NVIDIA DOCA™ software. BlueField and NVIDIA Sentry together provide in-silicon security enforcement — if an agent attempts to move outside its software boundary, NVIDIA Sentry quarantines and stops it in milliseconds. NVIDIA Sentry, powered by DOCA and running on BlueField-4, boosts agent capacity by up to 20%.

NVIDIA Partners Building Secure Agent Deployments With OpenShell
NVIDIA is working with industry leaders building infrastructure, models and software to enable industries to safely deploy agents in production.

The OpenShell Reference Architecture runs on leading enterprise operating systems and container orchestration layers, including Linux and Kubernetes infrastructure powered by Canonical, SUSE and Red Hat, as well as Microsoft Windows using Microsoft Execution Containers (MXC). It can run on cloud operating systems from Amazon Web Services, Google Cloud and Microsoft Azure.

Enterprises can run agents from model builders including Anthropic, Cohere, Google, Meta, OpenAI, Perplexity, Reflection and SpaceX Super Intelligence on OpenShell infrastructure. NVIDIA is also working with model builder partners on OpenShell deployments for advanced model research.

Cybersecurity leaders 1Password, Check Point, CrowdStrike, Cisco, F5, Fortinet, Microsoft, Okta, Palo Alto Networks, TrendAI and Zscaler are integrating support for the OpenShell Reference Architecture into their agent security solutions.

Leading banks — including Europe’s BBVA and Santander — are working with NVIDIA to explore the OpenShell Reference Architecture as a framework for strengthening agent safety, security and governance.

Enterprise software leaders Cadence, Dassault Systèmes, IBM, SAP, Siemens and Synopsys are working with OpenShell to build agent software platforms. Palantir and NVIDIA are working with customers to deploy secure agents in production.

SAP is integrating the NVIDIA OpenShell Reference Architecture with Joule Studio runtime, part of SAP Business AI Platform, connecting business governance with secure agent execution.

ServiceNow today announced the general availability of ServiceNow Arc, a personal long-running AI agent with actions governed at runtime by the ServiceNow Super Intelligence Control Tower and enforced by NVIDIA OpenShell. In addition, ServiceNow’s recently announced AI Passport authority layer carries those policies to NVIDIA OpenShell and NVIDIA Sentry, so enterprises can revoke an AI agent’s access across software and hardware within seconds.

NVIDIA system manufacturers Dell Technologies, Cisco, HPE, Lenovo and Supermicro are among those building infrastructure with the OpenShell Reference Architecture.

NVIDIA is also working with cloud service providers including CoreWeave, Crusoe, Firebird, Firmus, GMI Cloud, IREN, Lambda, Nebius, Nscale, Oracle Cloud Infrastructure and Vultr to deploy OpenShell-ready infrastructure.

Inference and post-training service providers including Baseten, Deepinfra, Fireworks and Together AI are building OpenShell Reference Architecture integrations into their model development pipelines.

Availability
The NVIDIA OpenShell Reference Architecture is now available.

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the world leader in AI and accelerated computing.

For further information, contact:
Corporate Communications
NVIDIA Corporation
press@nvidia.com

Certain statements in this press release including, but not limited to, statements as to: expectations with respect to growth, performance, availability, and benefits of NVIDIA’s products, services and technologies, and related trends and drivers; expectations with respect to NVIDIA’s third party arrangements, including with its collaborators and partners, and related deployments, availability and timing; expectations with respect to technology developments, and related trends and drivers; expectations with respect to enterprise adoption and deployment of AI agents and related safety, governance and control; projected market growth and trends; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing products and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; NVIDIA’s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on NVIDIA’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

Many of the products and features described herein remain in various stages and will be offered on a when-and-if-available basis. The statements above are not intended to be, and should not be interpreted as a commitment, promise, or legal obligation, and the development, release, and timing of any features or functionalities described for our products is subject to change and remains at the sole discretion of NVIDIA. NVIDIA will have no liability for failure to deliver or delay in the delivery of any of the products, features or functions set forth herein.

© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, and other NVIDIA product and service names are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries and regions. Other company, product, and service names may be trademarks of the respective companies with which they are associated.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/077e35f0-622d-4f90-8402-6f2bce21a913

FREUDENSTADT, Germany, Oct. 21, 2026 (GLOBE NEWSWIRE) — SCHMID Group N.V. (NASDAQ: SHMD) (the “Company” or “SCHMID”), a global leader in providing solutions for the electronics industry, today provided the following operational update following the completion of the third quarter of 2026.

Operational Update for the third quarter ended September 30, 2026

In the third quarter of 2026, the Company recorded order intake of €67.8 million and reported preliminary revenues of €24.0 million. Order intake in the third quarter more than doubled compared with the second quarter of 2026 (€30.7 million) and includes the repeat order exceeding €37 million announced on July 7, 2026. Cumulative order intake for the first nine months of 2026 amounts to €111.7 million, and revenues for the first nine months amount to €70.0 million.

The order backlog stood at €96.8 million as of September 30, 2026, compared with €54.8 million as of June 30, 2026. Order intake and order backlog figures relate exclusively to orders for equipment and do not include orders associated with services or spare parts.

Order momentum continuing into the fourth quarter

In a separate press release issued today, SCHMID announced that it has reached an agreement with one of its key customers and long-standing technology partner on an equipment order of more than €25 million to support the expansion of advanced High-Density Interconnect (HDI) manufacturing capacity in Malaysia. Of this order, more than €7 million was already included in order intake for the third quarter of 2026 with the remainder recorded as order intake in the fourth quarter of 2026.

Full-year 2026 guidance for order intake increased

For the full-year 2026, management confirms its guidance of revenues of more than €100 million and an Adjusted EBITDA margin of 6 to 9% (based on Adjusted EBITDA as defined in the Company’s press release dated August 25, 2026). Management increases its order intake guidance of from a range of €125 to €150 million to more than €150 million. The savings from our ‘Sprint’ I efficiency program progress as planned and “Sprint II” material cost savings program is showing first results.

Preliminary information and non-IFRS measures

The financial information presented in this press release for the third quarter of 2026, the first nine months of 2026 and the guidance for the full-year 2026 is preliminary and unaudited. Actual results may differ from the preliminary estimates presented herein. Order intake and order backlog are operational metrics used by management to evaluate the Company’s business activity and visibility of future revenue. These metrics are not measures defined under International Financial Reporting Standards (“IFRS”) and may not be comparable to similarly titled measures used by other companies.

Adjusted EBITDA is a non-IFRS financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, adjusted to exclude certain non-recurring or non-operational items. Because Adjusted EBITDA excludes items that may be included in the most directly comparable IFRS measure, investors should not consider Adjusted EBITDA in isolation or as a substitute for measures prepared in accordance with IFRS. The Company is unable to provide a reconciliation of forward-looking Adjusted EBITDA guidance to the most directly comparable IFRS financial measure without unreasonable effort because certain items that impact such measures are uncertain, out of the Company’s control and cannot be reasonably predicted.

Forward-looking Statements

This press release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding the Company’s preliminary third quarter and first nine months of 2026 results, financial outlook for fiscal year 2026, expected order intake and revenue growth, anticipated demand trends, and other statements that are not historical facts. There are a significant number of factors that could cause actual results to differ materially from the statements made in this press release. Additional risks and uncertainties that could affect our financial results are included under “Item 3. Key Information – 3.D. Risk Factors” in our annual report on Form 20-F filed with the SEC on May 15, 2026, which is available on the SEC’s website at www.sec.gov. Additional information will also be set forth in other filings that we make with the SEC from time to time. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by applicable law.

About the SCHMID Group

The SCHMID Group is a global leader in providing advanced equipment and process solutions for the high-tech industry, with a strong focus on electronics and semiconductor-related applications. Headquartered in Freudenstadt, Germany, and founded in 1864, SCHMID employs more than 800 people worldwide and operates technology centers and manufacturing facilities in Germany and China, as well as sales and service locations globally.

SCHMID develops customized systems and process solutions for the production of substrates, printed circuit boards and other electronic components. Its portfolio addresses a range of high-growth applications, including advanced packaging, semiconductor-related technologies, AI-driven electronics, printed circuit boards, substrates and glass-based technologies.

SCHMID’s solutions enable customers to achieve high technology levels, high yields, low production costs, maximum efficiency, quality, and sustainability in advanced manufacturing processes.

For more information about the SCHMID Group, please visit www.schmid-group.com or contact investor-relations@schmid-group.com.

Contact
Press@schmid-group.com

Octopus AIM VCT plc

Net Asset Value

Octopus AIM VCT plc announces that as at 19 October 2026 the unaudited net asset value of the Ordinary shares was approximately 39.9 pence per share.

For further information, please contact:

Ronan Goggin
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800C5JHJUQLAFP619

Octopus AIM VCT 2 plc

Net Asset Value

Octopus AIM VCT 2 plc announces that as at 19 October 2026 the unaudited net asset value of the Ordinary shares was approximately 31.9 pence per share.

For further information, please contact:

Andrew Humphries
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17

BROOKFIELD, Wis., Oct. 21, 2026 (GLOBE NEWSWIRE) — CIB Marine Bancshares, Inc. (the “Company” or “CIB Marine”) (OTCQX: CIBH), the holding company of CIBM Bank (the “Bank”), announced its unaudited results of operations and financial condition for the quarter and nine months ended September 30, 2026. Net income for the quarter was $0.8 million, or $0.58 basic and $0.57 diluted net income per share, compared to $0.9 million, or $0.67 basic and $0.65 diluted net income per share, for the same quarter of 2025. For the nine-month period, net income increased to $2.3 million, or $1.73 basic and $1.69 diluted net income per share, compared to $1.9 million, or $1.41 basic and $1.36 diluted net income per share, for the same period in 2025.

Financial highlights for the quarter include:

• Net interest margin increased to 3.05% compared to 3.03% for the second quarter of 2026 and 2.77% for the third quarter of 2025. In addition, the net interest margin increased to 3.02% for the nine months ended September 30, 2026, compared to 2.69% for the same period of 2025. The rising trend continued as the cost of funds declined and earning asset yields rose. Net interest income increased $0.5 million for the quarter compared to the same quarter of 2025, and by $1.5 million for the nine months ended September 30, 2026, compared to the same period of 2025, primarily as a result of improved net interest margins that more than offset the impact of lower average earning asset balances.

• Net income for the Banking Division increased by $0.5 million, while net income for the Mortgage Division decreased by $0.1 million for the nine months ended September 30, 2026, compared to the same period in 2025. The Banking Division’s increase was driven primarily by higher net interest income, which more than offset the $0.4 million increase in provisions for credit losses. The Mortgage Division’s results were primarily the result of lower mortgage volumes due to higher mortgage rates and limited housing inventory, offset in part by effective cost controls.
• The allowance for credit losses (“ACL”) to loans was 1.23% at September 30, 2026, compared to 1.20% at June 30, 2026, and 1.27% at December 31, 2025. Provision for credit losses increased year to date, and annualized net charge-offs also increased. Improved economic forecasts from the Federal Reserve and lower loan balances since June 30, 2026, partially offset deterioration in qualitative adjustments related to changes in credit classifications and other factors. Non-performing assets to total assets and non-accrual loans to loans were 0.92% and 1.15%, respectively, on September 30, 2026, compared to 1.04% and 1.31%, respectively, on December 31, 2025. While these measures of non-performing asset quality remained relatively consistent during the period, migration within other credit risk categories resulted in the combined total of credits classified as Special Mention, Substandard, and Doubtful increasing from $37 million at December 31, 2025, to $56 million at September 30, 2026. This increase was primarily due to migration in the Commercial and Commercial Real Estate loan portfolio segments, while the Construction & Development, Residential, Home Equity or Consumer segments experienced little overall total classified balance change. Management is closely monitoring these credits and has increased its focus on problem loan management.
• Since year-end 2025, loan balances have decreased by $15 million, primarily due to a $10 million and $5 million decline in the residential and commercial (inclusive of the construction and development segment) portfolios, respectively. The decline in residential loans was consistent with portfolio strategy, as these loans generally generate lower net interest spreads. Although commercial loan originations increased compared with the same period in the prior year, elevated prepayment activity, largely attributable to borrower business and property sales rather than interest rate or service considerations, contributed to the decline in commercial loan balances. Deposits increased since December 31, 2025, primarily in money market and noninterest-bearing checking accounts, reflecting targeted growth initiatives and increased marketing expenditures. Short-term borrowings, primarily those from the Federal Home Loan Bank of Chicago, decreased by $29 million during the period with that reduction funded from higher deposit balances and lower loan balances.

Mr. J. Brian Chaffin, CIB Marine’s President and CEO, commented, “Earnings improved again as expansion of the net interest margin and disciplined expense management more than offset higher provisions for credit losses. Net interest margin for CIBM Bank was 3.11% for the third quarter, up from 2.84% in the same quarter in 2025, and up from 3.09% in the second quarter of 2026. We remain focused on growing new customer relationships and continuing the repricing of loans and deposits, supported by enhanced marketing activities. Provisions for credit losses increased compared to the same period last year as we have had some credit migration and charge-off activity, as noted above. Management is addressing these issues with the highest priority.”

Regarding the Company’s common stock repurchase plan, he added, “Purchases of CIBH stock for the year to date have totaled $1.2 million at a weighted average price of $38.33 per share. Since February 2025, we have repurchased 5% of our outstanding stock at a price of $36.17 per share, utilizing $2.5 million of the $3.5 million authorized through 2026.”

Finally, he concluded, “For the remainder of 2026, we remain focused on increasing net interest income while navigating the challenges presented by the current interest rate environment, and on addressing the recent rise in loan risk migrations.”

CIB Marine Bancshares, Inc. is the holding company for CIBM Bank, which operates nine banking offices in Illinois, Wisconsin, and Indiana, and has mortgage loan officers and/or offices in six states. More information on the Company is available at www.cibmarine.com, including recent shareholder letters, links to regulatory financial reports, and audited financial statements.

FORWARD-LOOKING STATEMENTS
CIB Marine has made statements in this release that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. CIB Marine intends these forward-looking statements to be subject to the safe harbor created thereby and is including this statement to avail itself of the safe harbor. Forward-looking statements are identified generally by statements containing words and phrases such as “may,” “project,” “are confident,” “should be,” “intend,” “predict,” “believe,” “plan,” “expect,” “estimate,” “anticipate” and similar expressions. These forward-looking statements reflect CIB Marine’s current views with respect to future events and financial performance that are subject to many uncertainties and factors relating to CIB Marine’s operations and the business environment, which could change at any time.

There are inherent difficulties in predicting factors that may affect the accuracy of forward-looking statements.

Stockholders should note that many factors, some of which are discussed elsewhere in this Earnings Release and in the documents that are incorporated by reference, could affect the future financial results of CIB Marine and could cause those results to differ materially from those expressed in forward-looking statements contained or incorporated by reference in this document. These factors, many of which are beyond CIB Marine’s control, include but are not limited to:

• operating, legal, execution, credit, market, security (including cyber), and regulatory risks;
• economic, political, and competitive forces affecting CIB Marine’s banking business;
• the impact on net interest income and securities values from changes in monetary policy and general economic and political conditions; and
• the risk that CIB Marine’s analyses of these risks and forces could be incorrect and/or that the strategies developed to address them could be unsuccessful.

These factors should be considered in evaluating the forward-looking statements, and undue reliance should not be placed on such statements. Forward-looking statements speak only as of the date they are made. CIB Marine undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Forward-looking statements are subject to significant risks and uncertainties and CIB Marine’s actual results may differ materially from the results discussed in forward-looking statements.

FOR INFORMATION CONTACT:
J. Brian Chaffin, President & CEO
(217) 355-0900
brian.chaffin@cibmbank.com 

CIB MARINE BANCSHARES, INC.
Selected Unaudited Consolidated Financial Data
	At or for the
	Quarters Ended																9 Months Ended
	September 30,			June 30,			March 31,			December 31,			September 30,				September 30,			September 30,
		2026			2026			2026			2025			2025				2026			2025
	(Dollars in thousands, except share and per share data)
Selected Statement of Operations Data:
Interest and dividend income	$	10,871		$	10,739		$	10,586		$	10,881		$	10,780			$	32,196		$	32,738
Interest expense		4,816			4,739			4,760			5,208			5,196				14,315			16,389
Net interest income		6,055			6,000			5,826			5,673			5,584				17,881			16,349
Provision for (reversal of) credit losses		73			(26	)		268			1,174			(90	)			315			(39	)
Net interest income after provision for
(reversal of) credit losses		5,982			6,026			5,558			4,499			5,674				17,566			16,388
Noninterest income (1)		1,163			1,337			1,178			1,292			1,908				3,678			5,225
Noninterest expense		6,129			6,191			5,969			6,223			6,375				18,289			19,059
Income (loss) before income taxes		1,016			1,172			767			(432	)		1,207				2,955			2,554
Income tax expense (benefit)		249			257			181			(115	)		299				687			657
Net income (loss)	$	767		$	915		$	586		$	(317	)	$	908			$	2,268		$	1,897
Common Share Data:
Basic net income (loss) per share	$	0.58		$	0.69		$	0.45		$	(0.24	)	$	0.67			$	1.73		$	1.41
Diluted net income (loss) per share		0.57			0.68			0.43			(0.24	)		0.65				1.69			1.36
Dividend		0.00			0.00			0.00			0.00			0.00				0.00			0.00
Tangible book value per share (2)		60.67			61.56			61.09			60.95			60.72				60.67			60.72
Book value per share (2)		60.72			61.61			61.13			61.00			60.77				60.72			60.77
Weighted average shares outstanding – basic		1,318,554			1,317,498			1,310,842			1,334,388			1,350,097				1,314,251			1,345,941
Weighted average shares outstanding – diluted		1,345,372			1,345,498			1,349,513			1,379,094			1,396,512				1,345,372			1,393,086
Financial Condition Data:
Total assets	$	812,901		$	828,198		$	832,790		$	833,304		$	836,760			$	812,901		$	836,760
Loans		650,954			659,768			669,543			666,199			655,620				650,954			655,620
Allowance for credit losses on loans		(7,987	)		(7,903	)		(8,696	)		(8,465	)		(8,721	)			(7,987	)		(8,721	)
Investment securities		124,964			124,419			120,629			123,319			128,214				124,964			128,214
Deposits		671,675			666,633			677,349			660,614			702,078				671,675			702,078
Borrowings		49,186			67,804			62,265			77,817			39,245				49,186			39,245
Stockholders’ equity		80,065			81,245			80,647			81,414			81,789				80,065			81,789
Financial Ratios and Other Data:
Performance Ratios:
Net interest margin (3)		3.05	%		3.03	%		2.96	%		2.81	%		2.77	%			3.02	%		2.69	%
Net interest spread (4)		2.48	%		2.46	%		2.40	%		2.20	%		2.17	%			2.45	%		2.07	%
Noninterest income to average assets (5)		0.61	%		0.66	%		0.59	%		0.62	%		0.91	%			0.62	%		0.82	%
Noninterest expense to average assets		2.98	%		3.03	%		2.95	%		2.98	%		3.06	%			2.99	%		3.04	%
Efficiency ratio (6)		83.96	%		84.28	%		85.03	%		89.37	%		85.33	%			84.41	%		88.61	%
Earnings (loss) on average assets (7)		0.37	%		0.45	%		0.29	%		-0.15	%		0.44	%			0.37	%		0.30	%
Earnings (loss) on average equity (8)		3.73	%		4.53	%		2.90	%		-1.53	%		4.46	%			3.72	%		3.18	%
Asset Quality Ratios:
Nonaccrual loans to loans (9)		1.15	%		1.09	%		1.30	%		1.31	%		0.95	%			1.15	%		0.95	%
Nonperforming assets to total assets (10)		0.92	%		0.87	%		1.04	%		1.04	%		0.75	%			0.92	%		0.75	%
Nonaccrual loans, modified loans to borrowers experiencing
financial difficulty, loans 90 days or more past due and still accruing to total loans		2.00	%		1.94	%		2.20	%		2.36	%		2.38	%			2.00	%		2.38	%
Nonaccrual loans, OREO, modified loans to borrowers
experiencing financial difficulty, loans 90 days or more past due and still accruing to total assets		1.60	%		1.54	%		1.77	%		1.89	%		1.87	%			1.60	%		1.87	%
Allowance for credit losses on loans to total loans (9)		1.23	%		1.20	%		1.30	%		1.27	%		1.33	%			1.23	%		1.33	%
Allowance for credit losses on loans to nonaccrual loans,
modified loans to borrowers experiencing financial difficulty loans and loans 90 days or more past due and still accruing (9)		61.30	%		61.87	%		59.08	%		53.87	%		55.78	%			61.30	%		55.78	%
Net charge-offs (recoveries) annualized
to average loans (9)		0.01	%		0.47	%		-0.06	%		0.85	%		0.00	%			0.14	%		-0.01	%
Capital Ratios:
Total equity to total assets		9.85	%		9.81	%		9.68	%		9.77	%		9.77	%			9.85	%		9.77	%
Total risk-based capital ratio		14.11	%		13.84	%		13.53	%		13.67	%		13.90	%			14.11	%		13.90	%
Tier 1 risk-based capital ratio		11.34	%		11.10	%		10.80	%		10.94	%		11.15	%			11.34	%		11.15	%
Leverage capital ratio		9.04	%		8.95	%		8.83	%		8.80	%		8.88	%			9.04	%		8.88	%
Other Data:
Number of employees (full-time equivalent)		142			142			141			142			143				142			143
Number of banking facilities		9			9			9			9			9				9			9
(1) Noninterest income includes gains and losses on securities.
(2) Tangible book value per share is the stockholder equity less the carrying value of the preferred stock and less the goodwill and intangible assets, divided by the total shares of common outstanding. Book value per share is the stockholder equity less the liquidation preference of the preferred stock, divided by the total shares of common outstanding. Both book value measures are reported inclusive of the net deferred tax assets. As presented here, shares of common outstanding excludes unvested restricted stock awards.
(3) Net interest margin is the ratio of net interest income to average interest-earning assets.
(4) Net interest spread is the yield on average interest-earning assets less the rate on average interest-bearing liabilities.
(5) Noninterest income to average assets excludes gains and losses on securities.
(6) The efficiency ratio is noninterest expense divided by the sum of net interest income plus noninterest income, excluding gains and losses on securities.
(7) Earnings on average assets are net income divided by average total assets.
(8) Earnings on average equity are net income divided by average stockholders’ equity.
(9) Excludes loans held for sale.
(10)Nonperforming assets includes nonaccrual loans, nonaccrual securities, and other real estate owned.

CIB MARINE BANCSHARES, INC.
Consolidated Balance Sheets (unaudited)
	September 30,			June 30,			March 31,			December 31,			September 30,
		2026			2026			2026			2025			2025
	(Dollars in Thousands, Except Shares)
Assets
Cash and due from banks	$	6,258		$	8,893		$	9,584		$	8,102		$	19,016
Securities available for sale		122,863			122,235			118,436			121,110			126,017
Equity securities at fair value		2,101			2,184			2,193			2,209			2,197
Loans held for sale		3,434			7,976			6,160			8,640			7,287
Loans		650,954			659,768			669,543			666,199			655,620
Allowance for credit losses on loans		(7,987	)		(7,903	)		(8,696	)		(8,465	)		(8,721	)
Net loans		642,967			651,865			660,847			657,734			646,899
Federal Home Loan Bank stock		2,264			2,707			2,707			2,567			2,195
Premises and equipment, net		1,633			1,646			1,610			1,675			1,731
Accrued interest receivable		2,935			2,798			2,890			2,763			2,803
Deferred tax assets, net		12,030			11,503			11,589			11,440			11,745
Other real estate owned, net		–			–			–			–			–
Bank owned life insurance		6,809			6,752			6,695			6,641			6,589
Goodwill and other intangible assets		64			64			64			64			64
Other assets		9,543			9,575			10,015			10,359			10,217
Total assets	$	812,901		$	828,198		$	832,790		$	833,304		$	836,760
Liabilities and Stockholders’ Equity
Deposits:
Noninterest-bearing demand	$	87,229		$	88,840		$	86,243		$	85,637		$	95,307
Interest-bearing demand		77,072			82,241			91,209			86,577			107,512
Savings		254,953			233,642			232,493			218,515			222,450
Time		252,421			261,910			267,404			269,885			276,809
Total deposits		671,675			666,633			677,349			660,614			702,078
Short-term borrowings		39,366			57,992			52,462			68,022			29,458
Long-term borrowings		9,820			9,812			9,803			9,795			9,787
Accrued interest payable		1,189			1,335			1,237			1,468			1,456
Other liabilities		10,786			11,181			11,292			11,991			12,192
Total liabilities		732,836			746,953			752,143			751,890			754,971
Stockholders’ Equity
Preferred stock, $1 par value; 5,000,000 authorized shares at both September 30, 2026 and December 31, 2025; 7% fixed rate noncumulative perpetual issued; zero shares of series A and zero shares of series B convertible		–			–			–			–			–
Common stock, $1 par value; 75,000,000 authorized shares; 1,401,541 and 1,385,842 issued shares; 1,319,357 and 1,335,390 outstanding shares at September 30, 2026 and December 31, 2025, respectively (1)		1,402			1,402			1,398			1,386			1,386
Capital surplus		182,391			182,283			182,175			182,087			182,003
Accumulated deficit		(95,639	)		(96,406	)		(97,321	)		(97,907	)		(97,591	)
Accumulated other comprehensive income (loss), net		(5,091	)		(3,036	)		(2,765	)		(2,371	)		(2,808	)
Treasury stock, 82,906 shares on September 30, 2026 and 51,174 shares December 31, 2025 (2)		(2,998	)		(2,998	)		(2,840	)		(1,781	)		(1,201	)
Total stockholders’ equity		80,065			81,245			80,647			81,414			81,789
Total liabilities and stockholders’ equity	$	812,901		$	828,198		$	832,790		$	833,304		$	836,760
(1) Both issued and outstanding shares as stated here exclude 41,184 shares and 43,054 shares of unvested restricted stock awards at September 30, 2026 and December 31, 2025, respectively.
(2) Treasury stock includes 722 shares held by subsidiary bank CIBM Bank.

CIB MARINE BANCSHARES, INC.
Consolidated Statements of Operations (Unaudited)
	At or for the
	Quarters Ended																9 Months Ended
	September 30,			June 30,			March 31,			December 31,			September 30,				September 30,			September 30,
		2026			2026			2026			2025			2025				2026			2025
	(Dollars in thousands)
Interest Income
Loans	$	9,535		$	9,463		$	9,323		$	9,480		$	9,347			$	28,321		$	28,623
Loans held for sale		84			78			87			168			123				249			409
Securities		1,225			1,170			1,152			1,200			1,229				3,547			3,565
Other investments		27			28			24			33			81				79			141
Total interest income		10,871			10,739			10,586			10,881			10,780				32,196			32,738
Interest Expense
Deposits		4,324			4,180			4,185			4,660			4,772				12,689			14,596
Short-term borrowings		371			437			456			427			302				1,264			1,431
Long-term borrowings		121			122			119			121			122				362			362
Total interest expense		4,816			4,739			4,760			5,208			5,196				14,315			16,389
Net interest income		6,055			6,000			5,826			5,673			5,584				17,881			16,349
Provision for (reversal of) credit losses		73			(26	)		268			1,174			(90	)			315			(39	)
Net interest income after provision for
(reversal of) credit losses		5,982			6,026			5,558			4,499			5,674				17,566			16,388
Noninterest Income
Deposit service charges		56			46			43			62			62				145			186
Other service fees		(14	)		(11	)		(10	)		(10	)		(7	)			(35	)		(26	)
Mortgage banking revenue, net		874			1,072			820			1,021			1,483				2,766			4,047
Other income		242			208			173			178			239				623			695
Net gain (loss) on sale of securities available for sale		0			0			0			(10	)		0				0			0
Unrealized gain (loss) recognized on equity securities		(82	)		(9	)		(16	)		11			21				(107	)		64
Net gain on sale of SBA loans		87			31			168			40			110				286			271
Net gain on sale of assets and (writedowns)		0			0			0			0			0				0			(12	)
Total noninterest income		1,163			1,337			1,178			1,292			1,908				3,678			5,225
Noninterest Expense
Compensation and employee benefits		3,801			3,800			3,726			3,833			4,047				11,327			12,173
Equipment		517			510			521			589			577				1,548			1,719
Occupancy and premises		521			524			571			537			514				1,616			1,582
Data Processing		244			213			218			215			243				675			676
Federal deposit insurance		123			125			134			119			138				382			368
Professional services		223			236			178			169			205				637			701
Telephone and data communication		73			69			65			73			65				207			174
Insurance		81			54			94			71			92				229			231
Other expense		546			660			462			617			494				1,668			1,435
Total noninterest expense		6,129			6,191			5,969			6,223			6,375				18,289			19,059
Income (loss) from operations
before income taxes		1,016			1,172			767			(432	)		1,207				2,955			2,554
Income tax expense (benefit)		249			257			181			(115	)		299				687			657
Net income (loss)		767			915			586			(317	)		908				2,268			1,897
Net income (loss) allocated to
common stockholders	$	767		$	915		$	586		$	(317	)	$	908			$	2,268		$	1,897

CIB MARINE BANCSHARES, INC.
Credit Quality Indicators (unaudited)
	At September 30, 2026
	Pass		Special Mention		Substandard		Doubtful		Total Loans
	(Dollars in thousands)
Commercial	$	68,883	$	2,976	$	20,193	$	–	$	92,052
Commercial real estate:
Owner Occupied		76,863		7,472		5,630		0		89,965
Non-owner Occupied		240,668		0		13,912		0		254,580
Construction and Development		26,386		0		5,323		0		31,709
Residential Real Estate:
Owner Occupied		143,490		101		166		0		143,757
Non-owner Occupied		17,691		0		0		0		17,691
Home equity		18,947		241		437		0		19,625
Purchased home equity pools		157		0		0		0		157
Other consumer		739		1		0		0		741
	$	593,823	$	10,792	$	45,661	$	0		650,275
Deferred loan costs										679
Total									$	650,954
Combined total classified Special Mention, Substandard and Doubtful									$	56,452
	At December 31, 2025
	Pass		Special Mention		Substandard		Doubtful		Total Loans
	(Dollars in thousands)
Commercial	$	82,314	$	7,892	$	8,280	$	–	$	98,486
Commercial real estate:
Owner Occupied		82,261		1,001		5,492		0		88,753
Non-owner Occupied		252,380		6,794		2,001		0		261,175
Construction and Development		21,325		4,262		0		0		25,587
Residential Real Estate:
Owner Occupied		152,099		322		428		0		152,849
Non-owner Occupied		18,312		0		0		0		18,312
Home equity		19,000		325		538		0		19,862
Purchased home equity pools		186		0		0		0		186
Other consumer		22		1		0		0		23
	$	627,899	$	20,597	$	16,738	$	0		665,233
Deferred loan costs										966
Total									$	666,199
Combined total classified Special Mention, Substandard and Doubtful									$	37,335

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Reference is made to the announcement published 20 October 2026. All capitalised terms used and not otherwise defined herein shall have the meanings assigned thereto in the announcement unless the context otherwise requires. Tryg Forsikring A/S (the “Issuer”) has now determined the purchase price for the contemplated purchase of some or all of the outstanding SEK 1,300,000,000 Floating Rate Tier 2 Capital Notes, ISIN DK0030488101 (the “Existing Notes”). The purchase price will be 100.042 per cent. of their Outstanding Principal Amount (as defined in the terms and conditions of the Existing Notes) at the date of settlement of the purchase together with any accrued and unpaid interest to (but excluding) the date of settlement of the purchase. The Issuer’s purchase of the Existing Notes is conditional upon certain Purchase Conditions, among other things, the successful completion of the issuance and settlement of the Notes.

Additional information:
For further information, visit tryg.com or contact:
Head of Financial Reporting, Gianandrea Roberti at +45 20 18 82 67 or gianandrea.roberti@tryg.dk
Head of Investor Relations, Robin H. Løfgren at +45 41 86 25 88 or robin.loefgren@tryg.dk

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer, invitation or solicitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or otherwise in any jurisdiction in which such offer, invitation or solicitation is unlawful.

This announcement does not constitute a prospectus, prospectus equivalent document or an exempted document.

Attachment

• Tryg Forsikring AS Purchase Price Announcement

Long-standing strategic technology partnership reinforces SCHMID’s position in advanced electronics manufacturing

FREUDENSTADT, Germany, Oct. 21, 2026 (GLOBE NEWSWIRE) — SCHMID Group N.V. (NASDAQ: SHMD) (the “Company” or “SCHMID”), a leading global provider of advanced manufacturing equipment and solutions for the electronics industry, today announced that it has reached an agreement with one of its key customers and long-standing technology partners on a significant equipment order valued at more than €25 million to support the expansion of advanced High-Density Interconnect (HDI) manufacturing capacity in Malaysia.

The agreement represents another important milestone in a well-established technology partnership and reflects the continued confidence of leading global electronics manufacturers in SCHMID’s equipment solutions, process expertise and ability to support complex industrial expansion projects.

The planned capacity expansion addresses the increasing technological requirements of next-generation electronic applications, where higher interconnect density, greater manufacturing precision and consistent production quality are becoming increasingly important.

SCHMID will support the project with its advanced manufacturing technologies and extensive process know-how, enabling the customer to expand its production capabilities while maintaining the demanding quality and reliability standards required for high-volume manufacturing.

Executive Statement – Roland Rettenmeier, Chief Sales Officer (CSO) of SCHMID Group, commented:

“This significant agreement reflects the strength of our long-standing technology partnership and the continued confidence of leading industry players in SCHMID’s capabilities.

We are proud to support our customer’s expansion of advanced HDI manufacturing capacity in Malaysia. The project underlines the competitiveness of our technology, our ability to support demanding industrial-scale manufacturing requirements, and the value of close, long-term collaboration with our strategic customers.

It also reinforces SCHMID’s position as a trusted technology partner in the global advanced electronics industry.”

Strengthening SCHMID’s Position in Advanced Electronics Manufacturing

The agreement further highlights SCHMID’s participation in the ongoing expansion of advanced electronics manufacturing capacity across Southeast Asia, an increasingly important region within the global semiconductor and high-performance electronics supply chain.

With its established global customer relationships, advanced process technologies and comprehensive manufacturing expertise, SCHMID remains well positioned to support the industry’s transition towards increasingly sophisticated interconnect architectures and higher-density electronic applications.

About the SCHMID Group

The SCHMID Group is a global leader in providing advanced equipment and process solutions for the high-tech industry, with a strong focus on electronics and semiconductor-related applications. Headquartered in Freudenstadt, Germany, and founded in 1864, SCHMID employs more than 800 people worldwide and operates technology centers and manufacturing facilities in Germany and China, as well as sales and service locations globally.

SCHMID develops customized systems and process solutions for the production of substrates, printed circuit boards and other electronic components. Its portfolio addresses a range of high-growth applications, including advanced packaging, semiconductor-related technologies, AI-driven electronics, printed circuit boards, substrates and glass-based technologies.

SCHMID’s solutions enable customers to achieve high technology levels, high yields, low production costs, maximum efficiency, quality, and sustainability in advanced manufacturing processes.

For more information about the SCHMID Group, please visit www.schmid-group.com or contact investor-relations@schmid-group.com.

Contact

Press@schmid-group.com